1. Home >
  2. M&A >
  3. Divestiture >
  4. United States >
  5. Rhythm Pharmaceuticals Acquires Motus Therapeutics

M&A Deal Summary

Rhythm Pharmaceuticals Acquires Motus Therapeutics

On October 27, 2016, Rhythm Pharmaceuticals acquired life science company Motus Therapeutics from Allergan

Acquisition Highlights
  • This is Rhythm Pharmaceuticals’ 1st transaction in the Life Science sector.
  • This is Rhythm Pharmaceuticals’ 1st transaction in the United States.

M&A Deal Summary
Date 2016-10-27
Target Motus Therapeutics
Sector Life Science
Buyer(s) Rhythm Pharmaceuticals
Sellers(s) Allergan
Deal Type Divestiture

Target

Motus Therapeutics

Boston, United States
Motus Therapeutics, Inc. is a biopharmaceutical company developing peptide therapeutics for the treatment of gastrointestinal (GI) diseases.

Search 214,981 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Rhythm Pharmaceuticals

Boston, Massachusetts, United States
Category Company
Founded 2008
Sector Medical Products
DESCRIPTION

Rhythm is a biopharmaceutical company developing peptide therapeutics that address unmet needs in gastrointestinal diseases and obesity, including obesity caused by genetic deficiencies in the MC4 pathway.

DEAL STATS #
Overall 1 of 2
Sector: Life Science M&A 1 of 2
Type: Divestiture M&A Deals 1 of 1
Country: United States M&A 1 of 1
Year: 2016 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-10-22 Motus Therapeutics

Boston, United States

Motus Therapeutics, Inc. is a biopharmaceutical company developing peptide therapeutics for the treatment of gastrointestinal (GI) diseases.

Sell $40M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-02-27 Xinvento

Amsterdam, Netherlands

Xinvento is a biotech company focused on developing therapies for congenital hyperinsulinism (CHI). Xinvento was founded in 2021 and is based in Amsterdam, Netherlands.

Buy -

Seller(S) 1

SELLER

Allergan

Parsippany, New Jersey, United States
Category Company
Founded 1956
Sector Life Science
Employees31,200
Revenue 15.8B USD (2018)
DESCRIPTION

Allergan is an integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company was originally established in 1956 and is based in Parsippany, New Jersey.

DEAL STATS #
Overall 6 of 9
Sector: Life Science M&A 4 of 7
Type: Divestiture M&A Deals 6 of 9
Country: United States M&A 6 of 8
Year: 2016 M&A 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-09-20 Akarna Therapeutics

Cambridge, United Kingdom

Akarna Therapeutics Ltd. is a bio-pharmaceutical company, that develops novel small molecule therapeutics that target inflammatory and fibrotic diseases.

Buy $50M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-11-11 SERI Surgical Scaffold

Parsippany, New Jersey, United States

SERI Surgical Scaffold is a provider of silk based solutions to treat patients with soft-tissue defects.

Sell -
Mergr

Solution for

Product

Company

Legal